Minnesota adds alzheimer’s to qualifying conditions
Minnesota now has fourteen conditions that qualify patients for medical marijuana
Minnesota now has fourteen conditions that qualify patients for medical marijuana
The medical conditions added this month mark the first expansion to the list in six years.
Sativex® for the Treatment of AgitatioN in Dementia (STAND trial)
Suggestions will be finalised and confirmed by 1st December 2018
World Health Organisation report revealed that CBD oils may help successfully treat symptoms relating to Alzheimer’s Disease, Parkinson’s Disease, MS, pain, anxiety, depression, cancer and diabetic complications
The US DEA continues to stand by a decades-old assertion that marijuana and certain of its derivatives are as dangerous as heroin, in spite of a wealth of increasing evidence revealing that the opposite is true
“They call it my happy pill and I call it my happy pill,” Hanson laughs. A few times a day, 92-year-old Lucy Hanson takes a little capsule; in it is medical marijuana. It’s hard to believe when you talk to her now but, four years ago, Lucy was confused, falling down and speaking gibberish. She often lay…
You’ve probably heard this before.
As early as 2008, several reports, including one published in Molecular Pharmaceutics, began proposing various therapeutic pathways by which cannabinoids could treat Alzheimer’s Disease patients, but none were proven.